Clinical Trials Directory

Trials / Completed

CompletedNCT03185156

The Preventive Effects of Sub Hypnotic Dose of Propofol for Nausea and Vomiting Induced by Hemabate

The Preventive Effect of Sub Hypnotic Dose of Propofol for Nausea and Vomiting Induced by Hemabate

Status
Completed
Phase
Phase 4
Study type
Interventional
Enrollment
60 (actual)
Sponsor
West China Second University Hospital · Academic / Other
Sex
Female
Age
20 Years – 40 Years
Healthy volunteers
Not accepted

Summary

This is a randomized, placebo-controlled trail, the objective of this study is observation the effect of sub hypnotic dose of propofol for prevention of nausea and vomiting induced by hemabate during spinal anesthesia for elective cesarean section. The primary outcome is the presence of post-delivery intra-operative nausea and vomiting in parturients. The patients demographic characteristics, blood pressure, sensory block level, and the medications will be collected.

Conditions

Interventions

TypeNameDescription
DRUGPropofolfirst dose 0.3mg/Kg propofol, then 1mg/Kg/hr micro-pump
DRUGNormal salinefirst dose 0.03ml/Kg placebo saline, then 0.1ml/Kg/hr micro-pump

Timeline

Start date
2017-06-28
Primary completion
2018-01-29
Completion
2018-01-30
First posted
2017-06-14
Last updated
2018-10-23

Locations

1 site across 1 country: China

Source: ClinicalTrials.gov record NCT03185156. Inclusion in this directory is not an endorsement.

The Preventive Effects of Sub Hypnotic Dose of Propofol for Nausea and Vomiting Induced by Hemabate (NCT03185156) · Clinical Trials Directory